Kidney Neoplasms: all 973 studies

Page 9 of 10. Open to participants first (214), then studies with results posted, then the rest; newest registration first within each.

• TroVax Renal Immunotherapy Survival TrialCompletedNCT00397345Phase 3
• A Study of ZYC300 Administered With Cyclophosphamide Pre-DosingCompletedNCT00381173Phase 1
• Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerCompletedNCT00365287Phase 1/2
• Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United StatesCompletedNCT00340457
• Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerTerminatedNCT00323791Phase 2
• Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical TrialCompletedNCT00316901Phase 2
• S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney CancerWithdrawnNCT00311545Phase 2
• Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00310011Phase 2
• Vatalanib and Everolimus in Treating Patients With Advanced Solid TumorsCompletedNCT00303732Phase 1
• Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00301990Phase 2
• Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the BrainCompletedNCT00301847Phase 2
• Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaStatus unknownNCT00295997Not applicable
• Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal CarcinomaWithdrawnNCT00293527Phase 2
• Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00293501Phase 1/2
• Comparison of Immune Response Following Surgical Management of Renal TumorsTerminatedNCT00289146
• Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal CancerCompletedNCT00278369Early Phase 1
• Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney CancerCompletedNCT00278174Phase 2
• Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney CancerCompletedNCT00276835Early Phase 1
• Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or MyelomaCompletedNCT00276536Phase 1
• Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction.CompletedNCT00263107
• Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney CancerCompletedNCT00262886Phase 2
• Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By SurgeryTerminatedNCT00243009Phase 2
• TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN)CompletedNCT00241163Phase 3
• A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell CarcinomaCompletedNCT00226980Phase 2
• Comparison Between Surgery and Radiofrequency for Treatment of Renal TumorsTerminatedNCT00221728Phase 2/3
• OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell CarcinomaCompletedNCT00193154Phase 2
• Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) CancerCompletedNCT00134186Phase 2
• Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney CancerTerminatedNCT00126178Phase 3
• Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low IncidenceCompletedNCT00123773Phase 2
• Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous DiseaseCompletedNCT00118326Phase 1/2
• Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT00101608Phase 2
• Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell CancerCompletedNCT00100906Phase 2
• NGR-TNF in Treating Patients With Advanced Solid TumorsCompletedNCT00098943Phase 1
• Vaccine Therapy in Treating Patients With Kidney CancerCompletedNCT00096629Phase 1
• Lenalidomide in Treating Patients With Advanced or Unresectable Kidney CancerCompletedNCT00096525Phase 2
• Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney CancerCompletedNCT00095108Phase 1
• Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney CancerStatus unknownNCT00093522Phase 2
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney CancerCompletedNCT00093405Phase 2
• Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney CancerTerminatedNCT00091611Phase 1
• DNA Variations in the Gene in Young Patients With Wilms' TumorCompletedNCT00088803
• S0400, FR901228 in Treating Patients With Advanced Cancer of the UrotheliumTerminatedNCT00087295Phase 2
• Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney CancerCompletedNCT00082914Phase 2
• High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2Status unknownNCT00080977Phase 2
• Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationCompletedNCT00080873Not applicable
• Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the UrotheliumCompletedNCT00080795Phase 2
• Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell CancerCompletedNCT00077129Phase 2
• 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell CarcinomaCompletedNCT00075660Phase 2
• Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau SyndromeCompletedNCT00075348
• Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell TransplantationCompletedNCT00073879Not applicable
• Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell CarcinomaCompletedNCT00072150Phase 2
• Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)CompletedNCT00072046Phase 3
• S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With ChemotherapyCompletedNCT00066612Phase 2
• Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or UreterCompletedNCT00066352Phase 2
• Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)SuspendedNCT00065572Phase 2
• A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell CarcinomaCompletedNCT00059735Phase 2
• S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) CancerCompletedNCT00058318Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell CancerCompletedNCT00057889Phase 2
• ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic CancerCompletedNCT00056537Phase 1
• Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney CancerCompletedNCT00056095Phase 2
• Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney CancerCompletedNCT00054886Phase 2
• Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney CancerCompletedNCT00053820Phase 3
• Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney CancerCompletedNCT00053807Phase 3
• Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00053209Phase 2
• Chemotherapy Before and After Surgery in Treating Children With Wilm's TumorStatus unknownNCT00047138Phase 3
• Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney CancerCompletedNCT00045370Phase 1
• PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney CancerCompletedNCT00045279Phase 2
• Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney CancerCompletedNCT00042965Phase 2
• Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder CancerCompletedNCT00041106Phase 2
• Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerCompletedNCT00039429Phase 2
• BAY 59-8862 in Treating Patients With Advanced Kidney CancerStatus unknownNCT00039169Phase 2
• Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast CancerCompletedNCT00039052Phase 1
• EPO906 Therapy in Patients With Advanced Kidney CancerCompletedNCT00035243Phase 2
• Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2CompletedNCT00034281Phase 1
• Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2CompletedNCT00031564Phase 2
• UCN-01 in Treating Patients With Advanced or Metastatic Kidney CancerStatus unknownNCT00030888Phase 2
• Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal CancerCompletedNCT00030342Phase 1/2
• Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract CancerCompletedNCT00028860Phase 2
• Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00027664Phase 2
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00027573Phase 2
• Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney CancerWithdrawnNCT00025519Phase 2
• PS-341 in Treating Patients With Metastatic Kidney CancerCompletedNCT00025376Phase 2
• Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the KidneyStatus unknownNCT00025103Phase 2
• Chemotherapy in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00024388Phase 2
• Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract CancerCompletedNCT00022191Phase 3
• Ixabepilone in Treating Patients With Advanced Urinary Tract CancerCompletedNCT00021099Phase 2
• RPI.4610 in Treating Patients With Metastatic Kidney CancerCompletedNCT00021021Phase 2
• Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney CancerCompletedNCT00020540Phase 1
• Caspofungin Acetate in Treating Children With Fever and NeutropeniaCompletedNCT00020527Not applicable
• Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)CompletedNCT00019955Phase 2
• Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsCompletedNCT00019630Phase 1
• Interleukin-2 in Treating Patients With Metastatic Kidney CancerCompletedNCT00018941Phase 3
• PS-341 in Treating Patients With Metastatic Kidney CancerCompletedNCT00017329Phase 2
• Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney CancerCompletedNCT00016939Phase 2
• Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous TreatmentCompletedNCT00016237Phase 1
• Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal CancerStatus unknownNCT00016042Phase 1
• Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the UrotheliumCompletedNCT00014274Phase 2/3
• ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney CancerCompletedNCT00014183Phase 2
• S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary TractCompletedNCT00014144Phase 2
• Vaccine Therapy in Treating Patients With Kidney CancerTerminatedNCT00014131Phase 1
• ZD 1839 in Treating Patients With Metastatic Kidney CancerCompletedNCT00012337Phase 2

← Kidney Neoplasms overview